NCT07093697 - A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212 | Biotech Hunter

Enrollment

273

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

May 27, 2025

Study Completion Date

May 27, 2025

Conditions

Acute Bronchitis

Interventions

DRUG

DW5121

Participants receive DW5121, 2 tablets orally, DW51211 Placebo, 2 tablets orally, DW51212 Placebo, 1 tablets orally, 3 times a day after meals for 7 days

DRUG

DW51211

Participants receive DW5121 placebo, 2 tablets orally, DW51211, 2 tablets orally, DW51212 Placebo, 1 tablets orally, 3 times a day after meals for 7 days

DRUG

DW51212

Participants receive DW5121 placebo, 2 tablets orally, DW51211 placebo, 2 tablets orally, DW51212 , 1 tablets orally, 3 times a day after meals for 7 days

Trial Locations (8)

14584

Soonchunhyang University Bucheon Hospital, Bucheon-si

24253

Hallym University Chuncheon Sacred Heart Hospital, Chuncheon

42415

Yeungnam University Medical Center, Daegu

54538

Wonkwang University Hospital, Iksan

03181

Kangbuk Samsung Hospital, Seoul

05030

Konkuk University Medical Center, Seoul

05355

Hallym University Kangdong Sacred Heart Hospital, Seoul

08308

Korea University Guro Hospital, Seoul